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Abstract Previous studies indicated that transforming RNA,
derived from the 3P half of the U5 small nuclear RNA first stem
structure, suppressed the secretory protein translation in vitro.
Gap junctions facilitate homeostatic control of cell growth and
differentiation and their dysfunction has been correlated with
carcinogenesis. Here, we reported that transforming RNA
directly suppressed the gap junction protein, connexin 43,
translation and thereby inhibited functional gap junction function
in rat epithelial cells. Together with previous data, this implies
that altered expression of transforming RNA itself is a potential
mechanism in inhibiting gap junction function during
carcinogenesis. ß 2001 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
During the evolution of a normal cell to a premalignant
cell, then to a invasive, metastatic tumor cell, it goes from a
contact-inhibited, diploid cell to one that loses contact inhibi-
tion and growth control, becomes unable to terminally di¡er-
entiate and exhibits genomic instability. These phenotypes,
shared by all tumor cells derived from various tissues and
organs, have been postulated to be the result of the loss of
gap junction function, due to a number of di¡erent transcrip-
tional, translational or posttranslational mechanisms [1,2].
We have reported that the 3P half of the ¢rst stem structure
of U5 small nuclear RNA was capable of transforming nor-
mal rat ¢broblasts morphologically and driving them eventu-
ally into tumorigenic cells when expressed with a poly(A) tail
[3]. By using a pulse-chase labeling and immunoprecipitation
method, it was found that expression of the RNA resulted in
suppression of the extracellular matrix ¢bronectin protein syn-
thesis [3]. In reticulocyte lysate translation, this transforming
RNA had an ability to a¡ect, at the level of elongation, the
translation of preL-lactamase used as a model secretory pro-
tein with a signal peptide, blocking a physiological regulatory
function (probably elongation arresting function) played by a
signal recognition particle (SRP) and the ribosome [4]. A ma-
jority of secretory and membrane proteins and part of lyso-
somal proteins are synthesized through the SRP-mediated
translocation system [5^7]. Thus, these ¢ndings suggest that
the RNA might a¡ect exclusively the synthesis of those pro-
teins in a cell.
Gap junctions are one type of junctional complex that form
protein channels between adjacent cells and have a role in
maintaining cellular homeostasis by allowing direct transfer
of small cytoplasmic constituents [8^10]. They are composed
of transmembrane connexin (Cx) proteins [11]. The gap junc-
tion-mediated intercellular communication (GJIC) plays an
important role in the cellular responsiveness to the environ-
ment. Normal, contact-inhibited cells are characterized by
having functional GJIC. On the other hand, normal cells,
exposed to tumor promoting agents, and malignant tumor
cells are frequently characterized by reversible- or stable-dis-
rupted GJIC, respectively [1,2]. Thus, the disruption of GJIC
has been hypothesized to overcome the suppression of initi-
ated cells by the surrounding normal cells and to allow the
clonal expansion of preneoplastic cells, leading to an idea that
the Cx genes belong to a family of tumor suppressor genes
[12^15]. Combined with these observations, we expect that
the transforming RNA3S would also suppress the transla-
tion of gap junction proteins which would lead to the inhibi-
tion of GJIC. Here, we report that expression of the RNA in
rat liver epithelial WB-F344 cells, that have a high level ex-
pression of Cx43, numerous gap junctions, and a high per-
centage of communicating cells, results in a very low incidence
of communication with a remarkably decreased amount of
Cx43 proteins.
2. Materials and methods
2.1. Cell culture
The rat liver epithelial cell line WB-F344 [16] was cultivated in a
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modi¢ed Eagle’s medium supplemented with 7% fetal calf serum and
50 Wg/ml gentamicin. The cells were grown at 37‡C in an atmosphere
of 95% air/5% CO2.
2.2. Transfection of plasmid
The plasmids used in this study were p3S-PA, p3A-PA, and pSH-
PA that expressed RNA3S, RNA3A (antisense RNA3S), and
RNAPL (polylinker region of pSVneoHMTIIA-PA), respectively,
as described previously [3]. WB-F344 cells were plated at 5U104
cells/7 cm2 well in 2 ml of the medium. 24 h after plating, the cells
were transfected with 1 Wg of plasmid DNA as a lipofection (Gibco/
BRL, Gaithersburg, MD, USA). The cells were incubated with the
precipitate for 12 h and grown with fresh medium for 24 h. They were
thereafter selected in the medium containing 500 Wg/ml G418 (Gibco/
BRL) for 12 days by changing the medium every 3 days. The drug-
resistant cells were named WB-3S, WB-3A, and WB-PL, and em-
ployed for the following experiments at 3^4 weeks after transfection.
Several clones with p3S-PA were also established by using the ring-
cloning method until 3 weeks after transfection, taking advantage of
very rapid proliferation of WB-F344 cells (doubling time of approx-
imately 22 h).
2.3. Reverse transcription (RT)-polymerase chain reaction (PCR) of
Cx43, GAPDH and RNA3S
RNA was extracted with TRI reagent (molecular Research Center,
Inc., Cincinnati, OH, USA) according to the manufacturer’s protocol.
RT and PCR were carried out as described previously [17]. Detection
of the cDNA of RNA3S was performed by using the primers as
described previously [3]. Preliminary experiments demonstrated the
submaximal 23 cycles of PCR appropriated to avoid an ampli¢cation
plateau. The PCR products were analyzed on a 8% polyacrylamide gel
in 1U Tris^borate/EDTA bu¡er. Gels were stained with ethidium
bromide and photographed using Polaroid type 665 ¢lm.
2.4. Western blotting
Western blot analysis of Cx43 was performed as described previ-
ously [18]. Proteins were extracted from the cells by treatment with
2% sodium dodecyl sulfate (SDS) containing 2 mM phenylmethylsul-
fonyl £uoride, 10 mM iodoacetoamide, 1 WM leupeptin, 1 WM anti-
pain, 0.1 mM sodium orthovanadate, 5 mM sodium £uoride and then
sonicated for three 10 s pulses using a probe sonicator (Branson,
Danbury, CT, USA). Proteins were separated on 12.5% polyacryl-
amide gels and transferred to PVDF membranes at 20 V for 16 h.
Cx43 was detected using anti-Cx43 rabbit polyclonal antibody
(Zymed Co., San Francisco, CA, USA), followed by incubation
with horseradish peroxidase-conjugated secondary antibody and de-
tection with the ECL chemiluminescent detection reagent (Amersham
Co., Arlington Heights, IL, USA). As an internal control, the same
extracts were also probed with an antibody for actin (Sigma Chemical
Co., St. Louis, MO, USA). The intensity of the Cx43 protein bands
was normalized for that of actin.
2.5. Pulse-chase labeling and immunoprecipitation
Pulse-chase labeling and immunoprecipitation were carried out as
described previously [3]. Brie£y, WB-F344 cells, grown to 80% con-
£uence in a 25 cm2 well, were incubated for 30 min in methionine-free
medium without serum. They were then pulse-labeled for 2 h in 1 ml
of the same medium containing 100 mCi of 35S-protein labeling mix
(1175 Ci/mmol; New England Nuclear, Boston, MA, USA). At the
indicated times, the monolayer was lysed with 500 Wl of phosphate-
bu¡ered saline (PBS) containing 1% Triton X-100, 0.6% SDS, 100
U/ml aprotinin, 1 mM phenylmethylsulfonyl £uoride, 0.5 mg/ml
EDTA, 50 Wg/ml antipain, 0.5 Wg/ml leupeptin, 10 mM sodium £uo-
ride, and 1 mM sodium orthovanadate. An aliquot of lysate (2U106
cpm) was incubated with 2 Wl each rabbit anti-Cx43 antibody (Zymed
Co.) or rabbit anti-actin antibody for 8 h at 4‡C. 20 Wl of a 50%
protein A-Sepharose suspension (Sigma Chemical Co.) was added
and incubated for 2 h at 4‡C with gentle agitation. The beads were
washed six times in the washing bu¡er and incubated in 20 Wl of
2-fold concentrated electrophoresis sample bu¡er (100 mM Tris^
HCl, pH 6.8, 200 mM dithiothreitol, 4% SDS, 0.2% bromophenol
blue, and 20% glycerol) at 100‡C for 5 min. After removal of the
beads by centrifugation at 15 000 rpm for 1 min, the samples were
analyzed in 12.5% SDS^polyacrylamide gels. The gels were ¢xed with
40% methanol and 10% acetic acid, treated with Enlightening (New
England Nuclear), dried, and exposed to X-ray ¢lm.
2.6. Fluorescence redistribution after photobleaching (FRAP) assay
The quantitative FRAP assay for GJIC was performed as previ-
ously reported [19] with an ACAS Ultima laser cytometer (Meridian
Instruments, Inc., Okemos, MI, USA). Cultured cells in 35 mm dishes
were incubated with 5,6-carboxy£uorescein diacetate (7 Wg/ml in
Ca2/Mg2^PBS; Molecular Probes, Inc., Eugene, OR, USA) at
room temperature for 15 min. Cells were randomly selected under a
microscope with a 40U objective lens and photobleached to 20^40%
of their original £uorescence intensity. They were then examined for
recovery of £uorescence after 4 min to obtain the rates of recovery,
which were reported as %/min, where % = % of prebleaching £uores-
cence. Fluorescence recovery was corrected for £uorescence lost in
unbleached controls.
2.7. Immuno£uorescent staining of Cx43
Immunostaining of Cx43 in WB-F344 cells was performed with an
anti-Cx43 rabbit polyclonal antibody as described previously [16].
Brie£y, the cells were incubated with anti-CX43 diluted 1:100 in
PBS overnight at 4‡C, washed four times with PBS, and then incu-
bated with FITC-conjugated anti-rabbit antibodies (Jackson Immuno
Research Laboratories, Inc., West Grove, PA, USA) diluted 1:100 in
the bovine serum albumin/Tween/PBS bu¡er for 1^2 h at room tem-
perature. The cells were washed in the same bu¡er four times and
mounted with poly-aquamount (Polysciences, Niles, IL, USA).
Fig. 1. Morphology of WB-F344 cells with p3S-PA. WB-F344 cells
were transfected with p3S-PA, p3A-PA, or pSH-PA and selected
with G418 as described in Section 2. (A) Control WB; (B) WB-3S;
(C) WB-3S1; (D) WB-3S2; (E) WB-3S3; (F) WB-3A; (G) WB-PL.
Photographs were taken with bright-¢eld optics at U10 magni¢ca-
tion at 3^4 weeks after transfection.
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3. Results
3.1. Morphological alteration of WB-F344 cells with p3S-PA
The previous study demonstrated that RNA3S expressed
from p3S-PA altered rat 3Y1 cells morphologically [3]. To
obtain a transforming RNA producing cell line, WB-F344
cells were transfected with p3S-PA and selected with G418.
The established line with p3S-PA was named WB-3S. Simi-
larly, those with p3A-PA and pSH-PA were named WB-3A
and WB-PL, respectively. Of those lines, WB-3S was morpho-
logically much more spindle-shaped and showed a criss-cross
growth pattern at 3^4 weeks after transfection (Fig. 1). Three
subclones, WB-3S1, WB-3S2, and WB-3S3, which were de-
rived from parental WB-3S, also exhibited a growth pattern
similar to that of WB-3S. On the other hand, control WB,
WB-3A, and WB-PL grew in uniform monolayers of polygo-
nal cells and exhibited a clear contact-inhibited growth pat-
tern. This result suggests that RNA3S has an ability to alter
normal rat epithelial cells morphologically.
3.2. Transcription and translation of Cx43 in WB-F344 cells
with p3S-PA
The levels of Cx43 and RNA3S mRNAs were estimated
by using RT-PCR assays. The PCR products of Cx43 exhib-
ited almost the same band intensities in all lines tested and
those of GAPDH used as an internal marker the same (Fig.
2), when the intensities were determined by densitometric
scanning of the DNA bands (data not shown). The PCR
products of RNA3S were clearly detected in the cells with
p3S-PA, displaying the same DNA length as shown previously
[3]. It is evident that expression of RNA3S does not a¡ect
the transcription of Cx43.
Previously, RNA3S blocked elongation of the secretory
protein translation in reticulocyte lysate, resulting in suppres-
sion of the translation [4]. It is thus expected that the Cx43
translation would be a¡ected by the RNA, because the pre-
protein of Cx43 has a secretory signal peptide [20]. To ask
this, we ¢rst performed Western blot analysis to monitor the
Cx43 protein levels. Cx proteins are able to be phosphorylated
and the degree of phosphorylation can be examined by virtue
of the mobilities exhibited by the di¡erent phosphorylated
forms of the proteins on SDS^polyacrylamide gels [16]. As
shown in Fig. 3 (upper panel), three major Cx-immunoreac-
tive protein bands were clearly detectable in control WB, WB-
3A, and WB-PL. These bands correspond to the following
three forms of Cx43: the fastest migrating unphosphorylated
form (P0), the slowest migrating hyperphosphorylated form
(P2), and phosphorylated form (P1) migrating between P0
and P2. Each protein level of P0, P1, and P2 was markedly
lower in parental WB-3S and its subclones, WB-3S1, WB-3S2,
and WB-3S3, than in the other lines, exhibiting about 60^70%
reduction of P1 appeared most prominently when compared
to that of control WB (lower panel in Fig. 3). On the other
hand, there was no signi¢cant di¡erence in the actin protein
levels in all lines tested. In addition, it appeared that expres-
sion of RNA3S did not alter the Cx phosphorylation pat-
terns.
Next, we measured the levels of Cx43 and actin synthesis by
using a pulse-chase labeling and immunoprecipitation meth-
od. As shown in Fig. 4, the level of Cx43 synthesis decreased
markedly in all the RNA3S-expressing lines, whereas the
level of actin synthesis was not a¡ected. These results indicate
that expression of RNA3S results in direct inhibition of the
Cx43 translation.
3.3. GJIC in the RNA3S+-expressing lines
To examine the ability of WB-3S to communicate via gap
junctions, we carried out the FRAP assay that yielded a quan-
Fig. 2. Detection of Cx43 and RNA3S transcripts. RT-PCR assays
were carried out to detect Cx43 and RNA3S transcripts in WB-
F344 cells with p3S-PA. (1) Control WB; (2) WB-3S; (3) WB-3S1;
(4) WB-3S2; (5) WB-3S3; (6) WB-3A; (7) WB-PL. The PCR prod-
uct of GAPDH mRNA was used as an internal marker. Molecular
weight marker (PX174/HaeIII digest) is also shown in the m lane.
Fig. 3. Detection of Cx43 protein. Western blot analysis (upper pan-
el) and intensities of Cx43 protein bands (lower panel). (1) Control
WB; (2) WB-3S; (3) WB-3S1; (4) WB-3S2; (5) WB-3S3; (6) WB-
3A; (7) WB-PL. P0, P1, and P2 indicate unphosphorylated, phos-
phorylated, and hyperphosphorylated Cx43 protein, respectively. As
an internal control, the same extracts were also probed with an
antibody for actin. The intensities of Cx43 bands were quantitated
in help of the Desk scan II and software of NIH image 1.55f.
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titative estimation of GJIC. Fig. 5A shows the representative
of digitalized images performed in control WB and WB-3S.
This shows that the £uorescence recovery was markedly in-
hibited for each selected cell of WB-3S. As summarized in Fig.
5B, GJIC was remarkably a¡ected in all the RNA3S-ex-
pressing cells, reducing by 62^77% of recovery when com-
pared to that in control WB. Additionally, expression of
RNA3A and RNAPL did not inhibit GJIC.
We further examined localization of Cx43 proteins on the
plasma membrane by using an immunostaining method. As
shown in Fig. 6, the plaques on the membranes were less
evident in the RNA3S-expressing lines, whereas they were
readily apparent in the other. Combined with these results,
it is evident that the RNA3S-induced inhibition of GJIC is
due to direct suppression of the Cx translation.
4. Discussion
From the fact that transforming RNA blocks the synthesis
of a protein with a secretory signal peptide [4], in this study,
we have demonstrated that RNA3S has an ability to inhibit
GJIC by suppressing the synthesis of Cx43 protein. The
RNA3S-expressing WB-F344 cells, as shown in their altered
morphology, appeared to grow in a non-contact-inhibited
fashion than the non-RNA3S-expressing cells which exhib-
ited clear contact-inhibited growth. With the normal turn-over
of Cx due to a relative short half life, the decrease in GJIC
might be the result of a decrease in the replacement of new
gap junctions and the altered phosphorylation of Cx43. Ex-
pression of Cx43 mRNA was not a¡ected at all by RNA3S.
On the other hand, the decreased levels of Cx43 protein were
found to be due to direct suppression of the Cx translation.
Additionally, it appeared that Cx protein phosphorylation
was not changed by the RNA. Moreover, these results are
consistent with the previous observations that expression of
RNA3S resulted in morphological transformation of rat 3Y1
cells and suppression of the ¢bronectin protein translation [3].
Taken together, we conclude that transforming RNA sup-
presses directly the Cx43 translation and thereby inhibits
GJIC. Therefore, this is the ¢rst demonstration that GJIC is
inhibited by the action of a non-coding transcript de¢ned as a
novel transforming agent.
Fig. 4. Pulse-chase analysis of Cx43 turn-over in WB cell lines. Cultures were labeled for 2 h with 35S-protein labeling mix (100 WCi/ml) and
chased for 0^2 h in normal media. All cultures were immunoprecipitated with anti-Cx43 antibody or anti-actin antibody and then analyzed by
SDS^PAGE and £uorography.
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It is known that during carcinogenesis an initiated cell ulti-
mately loses its ability to perform homologous or heterolo-
gous GJIC, having fewer and smaller gap junctions with less
Cx proteins [1,21^24]. In addition, many tumor promoting
chemicals, transforming agents, including oncogene products,
are associated with the disruption of GJIC, though multiple
mechanisms [16,17,19,25^33]. Overexpression of the c-Ha-ras
oncogene in WB-F344 cells partially reduced GJIC. However,
v-myc overexpression did not a¡ect GJIC. Interestingly, co-
expression of the two resulted in nearly complete inhibition of
GJIC and in the formation of highly malignant cells [33].
Reduction of GJIC is, in and of itself, an apparent necessary
but insu⁄cient factor to bring about growth in soft agar or
tumorigenesis in vivo. There seems to be a requirement for
su⁄cient reduction of GJIC as shown by a dose-dependent
activation of the c-Ha-ras protein and tumorigenesis associ-
ated with the rat liver epithelial cells [34,35]. Moreover, even
with complete inhibition of GJIC caused by a mutation
[36,37], growth in soft agar and tumorigenesis of the rat liver
epithelial cells (WB-AB-1) was extremely low. The implication
is that it must be accompanied by an induced mitogenic signal
transducting system.
We have demonstrated that transforming RNA was capable
of inducing several phenotypes leading to malignancy such as
Fig. 5. Quantitative estimation of GJIC. (A) Digitalized images in control WB and WB-3S. GJIC in WB-F344 cells expressing RNA3S was
measured quantitatively by using the FRAP technique as described in Section 2. The images are shown before (prebleach), immediately after
(0 min) and 4 min after photobleaching of selected cells. Plots show the percentage of £uorescence recovery vs. time for each selected cell.
Data were collected for the background loss of £uorescence in an area with isolated cells (WB, area 7; WB-3S, area 8). (B) Fluorescence recov-
ery. The recovery in WB-F344 cells with each plasmid is compared to that in control WB. Values represent mean þ S.D. (n = 20^23).
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an altered morphology, an enhanced growth rate, a decreased
amount of extracellular matrix proteins, and a disrupted
GJIC. These alterations are only due to the ability of the
RNA to suppress the secretory protein synthesis. These ¢nd-
ings suggest that the RNA, by itself, may create a cellular
condition prerequisite for malignant transformation. Of these
early events in the multistep, multi-mechanism process of car-
cinogenesis, immortalization is essential [38^42]. It will be of
interest to investigate whether transforming RNA might a¡ect
a certain oncogene which activates telomerase in normal hu-
man cells.
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